Rare Disease -Prader Willi Deck

Client Challenge

A large pharma client wanted to evaluate the market size and potential of Prader-Willi Syndrome (PWS) in the Middle East/North Africa (MENA).

For evaluating the Market estimate, we used Hybrid Approach i.e., taking regard to both the Patient-based and Sales based approach. In view of the historical and current trends, we anticipated the market estimate for the next 10 years.
We created the Market Forecast model considering factors such as epidemiology of the disease (collected from Rare disease databases & Organizations) & its patient segmentations, unmet medical need, drug competitor factor, patient compliance, product price, marketed drugs- calibration based on actual sales and their impact in MENA geographies, emerging drugs and their impact, launch dates, market drivers and barriers, and other factors.

Estimated the Prader-Willi Syndrome (PWS) prevalence in the MENA markets based on the epidemiological studies
Analyzed the impact of emerging therapies approvals and launch on the current treatment algorithm from the KOLs outlook
Determined the competitive landscape of emerging therapies entering the PWS market.
Quantified the market size of PWS country-wise and therapy-wise.